pembrolizumab,pds0101
pds biotech,merck
['headandneck', 'pdsbio', 'pds bio']
ceo frank bedu-addo and chief medical officer dr. lauren v. wood recapped versatile-002 interim results for recurrent/metastatic #headandneckcancer #clinicaltrial and plans for versatile-003. click here for replay: #biotech #oncology #asco23 
PDS Biotech is a clinical-stage biotech company developing cancer therapies and infectious disease vaccines based on Versamune®, a T-cell activating technology.